Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 1 mg/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 1 mg/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 250 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 250 microgram/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/actuation pressurized suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/actuation pressurized suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 250 microgram/mL suspension for nebulizer |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |
Fluticasone propionate 250 microgram/mL suspension for nebulizer |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluticasone propionate (substance) |
Inferred relationship |
Some |
1 |